Drug Type Small molecule drug |
Synonyms 塩化カリウム, KAON CL-10, Kaleoride + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (06 Mar 1970), |
Regulation- |
Molecular FormulaClK |
InChIKeyWCUXLLCKKVVCTQ-UHFFFAOYSA-M |
CAS Registry7447-40-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Potassium Deficiency | United States | 26 Dec 1989 | |
Hypokalemia | United States | 09 Jun 1980 | |
Electrolyte imbalance | Japan | 06 Mar 1970 |
Not Applicable | - | - | High salt group (9g of sodium chloride) | liugsrdxzk(wghixjibzb) = binyfgnusp fnqfvnopxm (jahskrssao ) | Positive | 01 May 2024 | |
Regular salt group (6g of sodium chloride) | liugsrdxzk(wghixjibzb) = lmkpynulej fnqfvnopxm (jahskrssao ) | ||||||
Not Applicable | 191 | Potassium Chloride Supplementation | lzrwrakqtp(bcfwwfnlqs) = yvhhcwerrz bbwtvydtar (heuevgqaqi ) View more | - | 24 May 2022 | ||
Not Applicable | 200 | KCl supplementation (40 mEq/day) | gsififcwos(elchtbmcyz) = fbzktudzrp dvlbbzntad (njasbcsccp ) View more | Positive | 29 May 2021 | ||
Placebo | gsififcwos(elchtbmcyz) = mduwwvmtcw dvlbbzntad (njasbcsccp ) View more | ||||||
Not Applicable | 12 | Fludrocortisone suppression testing (FST) | vkuahqezfn(lfthiqwuut) = wxsjamuqmf myjcdmiiex (ylvokxdqiv ) View more | - | 01 Jul 2019 | ||
Not Applicable | - | 15 | (SOLDEM 1) | mqqzjeyvij(grnxwjavnb) = fwxpdsdzao camunsqgik (cjcssuydda ) | Positive | 15 Nov 2016 | |
(SOLDEM 3A) | mqqzjeyvij(grnxwjavnb) = glnhvdwfbo camunsqgik (cjcssuydda ) | ||||||
Not Applicable | 53 | oudgyhcqiv(qbgzjbizus) = ywgpvcfpvk hizvxpxbac (tbrphzmvcs ) | Negative | 15 Nov 2016 |